The stock of BioSig Technologies Inc. (BSGM) has gone up by 4.82% for the week, with a -18.16% drop in the past month and a -60.05% drop in the past quarter. The volatility ratio for the week is 12.16%, and the volatility levels for the past 30 days are 13.91% for BSGM. The simple moving average for the past 20 days is -5.16% for BSGM’s stock, with a -48.48% simple moving average for the past 200 days.
Is It Worth Investing in BioSig Technologies Inc. (NASDAQ: BSGM) Right Now?
and a 36-month beta value of 1.37. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
The average price predicted for BioSig Technologies Inc. (BSGM) by analysts is $3.08, which is $3.55 above the current market price. The public float for BSGM is 63.53M, and at present, short sellers hold a 4.02% of that float. On September 18, 2023, the average trading volume of BSGM was 763.27K shares.
BSGM) stock’s latest price update
BioSig Technologies Inc. (NASDAQ: BSGM) has experienced a rise in its stock price by 15.45 compared to its previous closing price of 0.43. However, the company has seen a gain of 4.82% in its stock price over the last five trading days. Zacks Investment Research reported 2023-08-25 that BioSig’s (BSGM) subscription model for PURE EP provides electrophysiologists and cardiology departments with flexibility.
Analysts’ Opinion of BSGM
Many brokerage firms have already submitted their reports for BSGM stocks, with ROTH Capital repeating the rating for BSGM by listing it as a “Buy.” The predicted price for BSGM in the upcoming period, according to ROTH Capital is $9 based on the research report published on March 30, 2020 of the previous year 2020.
BSGM Trading at -36.73% from the 50-Day Moving Average
After a stumble in the market that brought BSGM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -69.98% of loss for the given period.
Volatility was left at 13.91%, however, over the last 30 days, the volatility rate increased by 12.16%, as shares sank -19.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -56.92% lower at present.
During the last 5 trading sessions, BSGM rose by +4.82%, which changed the moving average for the period of 200-days by +17.25% in comparison to the 20-day moving average, which settled at $0.5162. In addition, BioSig Technologies Inc. saw 17.95% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BSGM starting from LONDONER KENNETH L, who purchase 15,600 shares at the price of $1.24 back on Jun 13. After this action, LONDONER KENNETH L now owns 2,507,020 shares of BioSig Technologies Inc., valued at $19,358 using the latest closing price.
LONDONER KENNETH L, the Chief Executive Officer of BioSig Technologies Inc., purchase 6,000 shares at $1.17 during a trade that took place back on Jun 12, which means that LONDONER KENNETH L is holding 2,491,420 shares at $7,040 based on the most recent closing price.
Stock Fundamentals for BSGM
Current profitability levels for the company are sitting at:
- -9533.22 for the present operating margin
- -152.80 for the gross margin
The net margin for BioSig Technologies Inc. stands at -9458.74. The total capital return value is set at -379.13, while invested capital returns managed to touch -398.15.
Based on BioSig Technologies Inc. (BSGM), the company’s capital structure generated 183.01 points at debt to equity in total, while total debt to capital is 64.67. Total debt to assets is 18.61, with long-term debt to equity ratio resting at 144.41. Finally, the long-term debt to capital ratio is 38.21.
When we switch over and look at the enterprise to sales, we see a ratio of 136.46, with the company’s debt to enterprise value settled at 0.04. The receivables turnover for the company is 5.20 and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.35.
Conclusion
To sum up, BioSig Technologies Inc. (BSGM) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
